Trial intelligence / Profile preview

Steroid-free immunosuppression in paediatric liver transplantation

2007-004822-26Phase 3Completed

Sponsor
Birmingham Children's Hospital
Start
Nov 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of prednisolone in acute rejection (AR) (2 arms), sponsored by Birmingham Children's Hospital. Primary endpoint: Histologically proven acute rejection within 12 months. Started Nov 2007; status: completed.

02

Drugs

prednisolone
03

Conditions

acute rejection (AR)

Beyond the preview

Go deeper on 2007-004822-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004822-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call